ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Adult obesity prevalence remains high, prevention and treatment needed Adult obesity prevalence remains high, prevention and treatment needed

Adult obesity prevalence remains high, prevention and treatment needed

0 3314

According to the most recent population data from CDC, 22 states have an adult obesity prevalence at or above 35%, up from 19 states in 2021. In contrast, no state had an adult obesity prevalence at or above 35% a decade ago.

CDC recommends RSV vaccine for pregnant individuals CDC recommends RSV vaccine for pregnant individuals

CDC recommends RSV vaccine for pregnant individuals

0 4115

A CDC advisory panel has recommended the use of Pfizer’s bivalent RSVpreF respiratory syncytial virus (RSV) vaccine for pregnant people. The vaccine is designed to protect newborn babies from the respiratory disease.

Obesity-related CVD deaths tripled, highest for Black women Obesity-related CVD deaths tripled, highest for Black women

Obesity-related CVD deaths tripled, highest for Black women

A new study published in the Journal of the American Heart Association revealed that heart disease is linked to fewer deaths among Americans in...
0 3092
ADHD med errors for children happen more often than they should ADHD med errors for children happen more often than they should

ADHD med errors for children happen more often than they should

Researchers say more therapeutic errors involving ADHD medications among children are being reported to poison control centers across the country....
0 5447

Psilocybin may be safe and effective as treatment for MDD

Results from a new study published in JAMA find that among patients with major depressive disorder (MDD), a single 25-mg dose of psilocybin led to a steady reduction in depressive symptoms and helped improve psychosocial functioning. The goal of the research was to examine the safety and efficacy of using psilocybin in patients with MDD.

Could GLP-1s benefit T1D patients, too?

The popular GLP-1 receptor agonists, originally approved for T2D, may also be beneficial for patients with T1D—at least, that’s what findings from a small study published in NEJM imply.

First2345791011Last
ADVERTISEMENT